相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atomic force microscopy-single-molecule force spectroscopy unveils GPCR cell surface architecture
Etienne Dague et al.
COMMUNICATIONS BIOLOGY (2022)
Inverse agonist efficacy of selatogrel blunts constitutive P2Y12 receptor signaling by inducing the inactive receptor conformation
Veronique Pons et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Arrestin-3 differentially regulates platelet GPCR subsets
James L. Hutchinson et al.
PLATELETS (2020)
Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection via P2Y1 Antagonism in Mice
Mariana Alves et al.
FRONTIERS IN PHARMACOLOGY (2020)
Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4
Cristina Perpina-Viciano et al.
MOLECULAR PHARMACOLOGY (2020)
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists
Ali Isbilir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
GPCR homo-oligomerization
Graeme Milligan et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
Cedric Garcia et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model
Nicole Reichenbach et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
Elena Smolensky Koganov et al.
SCIENTIFIC REPORTS (2018)
Astroglial Ca2+-Dependent Hyperexcitability Requires P2Y(1) Purinergic Receptors and Pannexin-1 Channel Activation in a Chronic Model of Epilepsy
Mario Wellmann et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies
Dominick J. Angiolillo et al.
CIRCULATION (2017)
Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus
Liang Hu et al.
CIRCULATION (2017)
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis
Thomas Gremmel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
Riyaad Aungraheeta et al.
BLOOD (2016)
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor
Segolene Galandrin et al.
HYPERTENSION (2016)
Dyspnea related to reversibly-binding P2Y(12) inhibitors: A review of the pathophysiology, clinical presentation and diagnostics
Martin Unverdorben et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Platelet function and ageing
Chris I. Jones
MAMMALIAN GENOME (2016)
Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function
Stefan Gahbauer et al.
FRONTIERS IN PHYSIOLOGY (2016)
Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling
Celine M'Kadmi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The experimental power of FR900359 to study Gq-regulated biological processes
Ramona Schrage et al.
NATURE COMMUNICATIONS (2015)
Novel antiplatelet agents in acute coronary syndrome
Francesco Franchi et al.
NATURE REVIEWS CARDIOLOGY (2015)
Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking
Dong Soo Kang et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model
Andrea Delekate et al.
NATURE COMMUNICATIONS (2014)
Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y1 Antagonists
Hannguang Chao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
Jin Hwa Kim et al.
DIABETES & METABOLISM JOURNAL (2013)
Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12
Y. Zhang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Deciphering biased-agonism complexity reveals a new active AT1 receptor entity
Aude Sauliere et al.
NATURE CHEMICAL BIOLOGY (2012)
An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets
Shaista Nisar et al.
BLOOD (2011)
Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients
Konstantinos Stellos et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Platelet P2Y12 receptor inhibition by thienopyridines: status and future
Italo Porto et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Constitutive and agonist-induced dimerizations of the P2Y1 receptor -: Relationship to internalization and scaffolding
Roy C. Y. Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Agonist-selective, Receptor-specific Interaction of Human P2Y Receptors with β-Arrestin-1 and-2
Carsten Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
P2Y1 Receptor Activation Elicits Its Partition out of Membrane Rafts and Its Rapid Internalization from Human Blood Vessels: Implications for Receptor Signaling
Andres Norambuena et al.
MOLECULAR PHARMACOLOGY (2008)
Constitutive activation of G protein-coupled receptors and diseases: Insights into mechanisms of activation and therapeutics
Ya-Xiong Tao
PHARMACOLOGY & THERAPEUTICS (2008)
Distinct clathrin-coated pits sort different G protein-coupled receptor cargo
Stuart J. Mundell et al.
TRAFFIC (2006)
The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts
Pierre Savi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice
B Hechler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets
AR Hardy et al.
BLOOD (2004)
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist
N Lenain et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Identification of the platelet ADP receptor targeted by antithrombotic drugs
G Hollopeter et al.
NATURE (2001)
分享论文
